Stockscreener 앱 받기
137.79
2.18%
-2.54
Moderna Inc 주식(MRNA)의 최신 뉴스
Moderna stock heads into the open after a 1.8 percent drop - AD HOC NEWS
Discipline and Rules-Based Execution in MRNA Response - Stock Traders Daily
Moderna (NASDAQ: MRNA) withholds 5,704 shares for legal chief’s RSU taxes - Stock Titan
Moderna (NASDAQ: MRNA) CFO now holds 106,179 unvested RSUs - Stock Titan
What to know about a first-of-its kind flu shot for people over 50 - NBC 5 Chicago
Merck and Moderna Announce Positive Phase 3 Results for Intismeran Autogene Plus Pembrolizumab in High-Risk MelanomaThe Babak Lab - Oncodaily
MRNA Stock Soars 143% in a Month: Time to Buy, Hold or Sell? - Yahoo Finance
Merck Trading Near 52-Week High: Is the Stock a Buy, Hold or Sell? - The Globe and Mail
Merck Trading Near 52-Week High: Is the Stock a Buy, Hold or Sell? - Zacks Investment Research
Moderna Inc. stock gains sharply as cancer vaccine data lifts valuation - AD HOC NEWS
Nykredit A S Invests $913,000 in Moderna, Inc. $MRNA - MarketBeat
Moderna Inc. stock gains strongly as cancer vaccine partnership fuels rally - AD HOC NEWS
Moderna Stock (MRNA) Opinions on Melanoma Vaccine Trial Results - Quiver Quantitative
How Is Moderna's Stock Performance Compared to Other Healthcare Stocks - Yahoo Finance
Moderna, Inc. (MRNA) Stock Analysis: Is the Biotech Giant’s Market Cap Justified Amid a 19.96% Potential Downside? - DirectorsTalk Interviews
Alibaba DAMO Academy's Liver Cancer AI Model Tops Nature Medicine; Clinical Trial Catches 15 Missed Diagnoses - finance.biggo.com
Moderna Expands mRNA Territory Beyond Personalized Cancer Vaccines to Universal Shots and In Vivo CAR-T - finance.biggo.com
Moderna Moves Beyond Personalized Cancer Vaccines to Universal Shot - Seoul Economic Daily
Moderna Inc. stock holds steady as investors watch vaccine revenue and oncology pipeline - AD HOC NEWS
MRNA Looks 503.7% Overvalued on GF Value™ - GuruFocus
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It - MarketBeat
If You'd Invested in Moderna (MRNA) Stock 5 Years Ago, Here's How Much You'd Have Today (Hint: You'd Be Disappointed -- But Not If You Bought It 1 Year Ago.) - Yahoo Finance
AlphaGrep UK Ltd Invests $568,000 in Moderna, Inc. $MRNA - MarketBeat
Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreakABC News - ABC News - Breaking News, Latest News and Videos
Promising Biotech Stocks Worth WatchingSeptember 5th - MarketBeat
MRNA Looks 503.4% Overvalued on GF Value™ - GuruFocus
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks - Seeking Alpha
Personalized Cancer Vaccine Breakthrough Ignites Sequencing Sector, Tempus AI's Personalis Bid Faces Rivalry Speculation - finance.biggo.com
Step Capital Management Pte. Ltd. Has $48.67 Million Stake in Moderna, Inc. $MRNA - MarketBeat
22,477 Shares in Moderna, Inc. $MRNA Acquired by AXQ Capital LP - MarketBeat
The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels. - WSJ
What Does Moderna (MRNA) Bird Flu Phase 3 Trial Mean For Its Growth? - Yahoo Finance
Is Moderna (MRNA) Fully Valued After Its New 2032 Convertible Notes? - Yahoo Finance
Moderna's mRNA flu vaccine, mFlusiva, offers option for adults 50-64 with potential benefits over traditional shot - ABC7 New York
Moderna (MRNA) Stock Looks Expensive On Sales After A Very Large Run - Yahoo Finance
Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run? - Yahoo Finance
Healthcare Stocks To Watch TodaySeptember 4th - MarketBeat
Moderna stock falls after Rothschild Redburn downgrade - AD HOC NEWS
GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank says - Yahoo! Finance Canada
Moderna Inc (MRNA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why Moderna (MRNA) Stock Is Down Today - Yahoo Finance
Moderna is now overvalued after cancer vaccine-led stock surge, Rothschild & Co. says - CNBC TV18
BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now? - The Globe and Mail
Moderna (MRNA) Price Forecast: Bullish Pennant Points Toward Higher Targets - FXEmpire
Moderna (NASDAQ:MRNA) Insider Sells $485,766.45 in Stock - MarketBeat
Moderna (MRNA) CFO has 2,475 stock units vest in Sept. award - Stock Titan
Moderna (MRNA) legal chief trades stock under 10b5-1 plan - Stock Titan
MRNA Looks 500.3% Overvalued on GF Value™ - GuruFocus
Can Moderna reclaim 52-week highs after pullback, or have best levels been seen? - Investing.com
Why Moderna's Cancer Vaccine Matters To Investors - Seeking Alpha
Moderna stock slips as Rothschild downgrades (MRNA:NASDAQ) - Seeking Alpha
Moderna’s Cancer Vaccine Rally Sparks Rare Sell Rating and Projected 44% Stock Drop - Barron's
Does Moderna's mRNA Flu Shot Face a New Challenge From GSK? - Yahoo Finance
This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock Picks - Yahoo Finance
Moderna (NASDAQ:MRNA) Shares Gap Down on Analyst Downgrade - marketbeat.com
MRNA Downgraded by Rothschild & Co -- Price Target Raised to $81 - GuruFocus
Rothschild & Co Redburn Downgrades Moderna (NASDAQ:MRNA) to Sell - MarketBeat
Moderna: Massive Asymmetry About What The mRNA Is! (NASDAQ:MRNA) - Seeking Alpha
Rothschild Redburn downgrades Moderna stock on valuation concerns By Investing.com - Investing.com India
A cancer vaccine is closer than ever - themalaysianreserve.com
Jim Cramer Explains Why Heavily Shorted Moderna (MRNA) Has Room to Run - Yahoo Finance
MRNA Stock Pulls Back to $150 as Moderna Faces Key Test Ahead - FXLeaders
Moderna Stock Moves Lower Wednesday: What's Going On? - Benzinga
Moderna (MRNA) Stock Climbs Nearly 4% Following Melanoma Trial Success and Vaccine Approval - Blockonomi
Merck, Moderna report positive Phase 3 results for personalized melanoma vaccine - BusinessMirror
Cathie Wood Sells $15.6 Million of Tempus AI Stock After Merck-Moderna Trial Win, Ark Keeps Selling AMD Shares - Benzinga
Did Merck’s (MRK) First Positive Phase 3 Individualized mRNA Cancer Trial Just Redefine Its Moat? - Yahoo Finance
Moderna (MRNA) Completes $3 Billion Zero-Coupon Convertible Seni - GuruFocus
Moderna Announces $2.0 Billion Convertible Notes Offering - Minichart
Moderna Target of Unusually Large Options Trading (NASDAQ:MRNA) - MarketBeat
Moderna Announces $3 Billion Zero-Coupon Convertible Senior Notes Offering Maturing in 2032 - Kalkine Media
Moderna Raises $3 Billion via Convertible Notes Offering - tipranks.com
Moderna (NASDAQ:MRNA) Upsizes Convertible Notes Offering - Kalkine Media
Moderna Raises $3.0 Billion via 2032 Zero-Coupon Converts; Adds Capped Calls to Limit Dilution - TradingView
Moderna (NASDAQ: MRNA) takes on $3B in zero-interest debt that can turn into shares - Stock Titan
MRNA Stock Explodes As Cancer Breakthrough Resets Bull Case - StocksToTrade
1.83%
자본화:
|
볼륨(24시간):